Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04411420 · ClinicalTrials.gov registry record · NA
Improving Veteran Access to Integrated Management of Back Pain
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 1,817
- Enrollment target
NCT04411420: Completed NA study, sponsored by Duke University.
NCT04411420 is a NA study that has completed, run by Duke University. The registered enrollment target is 1,817 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04411420, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,817 participants
- Enrollment target
Study Summary
The purpose and objective of this pragmatic trial is to examine the effectiveness of two different quality improvement care pathways for low back pain (LBP); a sequenced, integrated care pathway (ICP) and 2) a coordinated, care management pathway (CCP). We will test the central hypothesis that the ICP will reduce pain interference with normal activities and improve physical function, as measured by Patient Reported Outcomes Measurement Information System (PROMIS) Short Form scores when compared to the CCP.
Primary Outcome
The PROMIS Short form scores will be collected by the clinical providers within the medical record at baseline and three months to measure pain interference. The pain interference form asks the participant to rate a series of pain related questions on a scale of 1-5 within the past seven days with 1 representing a better outcome. Ratings are summed across the four questions and converted to a standardized T-score (mean 50, standard deviation 10) according to PROMIS Scoring tables. Observations w
Interventions
- BEHAVIORAL Pain modulation with physical pain treatment
- BEHAVIORAL Telephone delivered self-management counseling for increasing physical activity
- BEHAVIORAL Telephone delivered behavioral treatment for participants with high risk for continued disability
- BEHAVIORAL Patient preference treatment protocol
- BEHAVIORAL Nonpharmacological guideline adherent treatment protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,817 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2025-01-15 |
| Phase | NA |
What the finished NCT04411420 record still lists
NCT04411420 is an interventional study that assigns participants to a tested intervention. Its 1,817 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% higher).
The record links to 0 conditions, and to 5 interventions - of which Pain modulation with physical pain treatment is the first listed.
NCT04411420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04411420 about?
NCT04411420 is a clinical study titled "Improving Veteran Access to Integrated Management of Back Pain". The purpose and objective of this pragmatic trial is to examine the effectiveness of two different quality improvement care pathways for low back pain (LBP); a sequenced, integrated care pathway (ICP) and 2) a coordinated, care management pathway (CCP). We will test the central hypothesis that the I...
What is the current status of trial NCT04411420?
This trial is currently completed. It is a NA study. The enrollment target is 1,817 participants. The study started on 2021-03-08. Estimated completion is 2025-01-15.
What interventions are being tested in trial NCT04411420?
The interventions under investigation include: Pain modulation with physical pain treatment (BEHAVIORAL), Telephone delivered self-management counseling for increasing physical activity (BEHAVIORAL), Telephone delivered behavioral treatment for participants with high risk for continued disability (BEHAVIORAL), Patient preference treatment protocol (BEHAVIORAL), Nonpharmacological guideline adherent treatment protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT04411420?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04411420's enrollment target sits among peer trials
1,817 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI